Cyscale

CyscaleCyscale
Cyscale

Cyscale

Cloud security credits to monitor and secure its cloud environment, helping to detect misconfigurations, vulnerabilities, and potential threats.

DR 472021Active5Tel Aviv, Israel
Rate

About

Cyscale offers a Cloud-Native Application Protection Platform (CNAPP) that unifies Cloud Security Posture Management (CSPM) and cloud vulnerability management. The platform helps security and engineering teams find, prioritize, and remediate cloud risks faster by correlating posture drift, CVEs, identity exposure, and attack paths. Cyscale serves security, platform, and compliance teams looking to secure multi-cloud environments.
Frequently asked

What does Cyscale do?

Cyscale offers a Cloud-Native Application Protection Platform (CNAPP) that unifies Cloud Security Posture Management (CSPM) and cloud vulnerability management. The platform helps security and engineering teams find, prioritize, and remediate cloud risks faster by correlating posture drift, CVEs, identity exposure, and attack paths. Cyscale serves security, platform, and compliance teams looking to secure multi-cloud environments.

What is Cyscale's revenue?

StartupHub estimates Cyscale's annual revenue at $1.2M (range $833K to $1.9M, 66% confidence), based on comparable companies in the sector.

What is Cyscale's valuation?

StartupHub estimates Cyscale's effective valuation at $13.0M (range $8.8M to $21.0M, 10% confidence), based on comparable companies in the sector.

How much funding has Cyscale raised?

Cyscale has raised a total of $4M in funding. The most recent round on record is Seed.

Where is Cyscale headquartered?

Cyscale is headquartered in Tel Aviv, Israel.

When was Cyscale founded?

Cyscale was founded in 2021.

What industry does Cyscale operate in?

Cyscale operates in Cloud Security, Cybersecurity, DevSecOps, Threat Detection, Vulnerability Management, Cloud Infrastructure.

How many employees does Cyscale have?

Cyscale has approximately 5 people on record.

HEADCOUNT
5
DOMAIN RATING
47
Comments

No comments yet. Be the first to share your take.